FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort.
about
Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapySecond-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives.Metastatic gastric cancer treatment: Second line and beyond.A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric CancerBiomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience.Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer.Eastern Canadian Colorectal Cancer Consensus Conference 2017Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
P2860
Q35005019-53BE268E-756A-4264-B26C-984C976241FFQ36453663-707E1F81-616F-4F61-A455-5D91467FD598Q38632917-B2782D0D-B625-49DB-84D1-D6145DC4232BQ42957434-81C3DA90-B70A-4E28-BFF7-2D546FDD3492Q49645479-C8DE8AAF-291D-441D-BECC-5767B78AE262Q49898050-5FB7B46A-02E9-4594-AEB4-89E47DDED4BDQ55155589-3FCAD527-C07E-42FF-ADDE-34E54B5405ECQ58783221-28C7E205-96FD-46D9-A7C8-545509A54B36Q59138471-58481A47-43A7-45E7-AF23-E9053757AEDF
P2860
FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FOLFIRI as a second-line thera ...... c cancer: a historical cohort.
@en
FOLFIRI as a second-line thera ...... c cancer: a historical cohort.
@nl
type
label
FOLFIRI as a second-line thera ...... c cancer: a historical cohort.
@en
FOLFIRI as a second-line thera ...... c cancer: a historical cohort.
@nl
prefLabel
FOLFIRI as a second-line thera ...... c cancer: a historical cohort.
@en
FOLFIRI as a second-line thera ...... c cancer: a historical cohort.
@nl
P2093
P2860
P50
P356
P1476
FOLFIRI as a second-line thera ...... ic cancer: a historical cohort
@en
P2093
Antonella Amodio
Franca Belli
Laura Pizzuti
Luigi Di Lauro
Sara Boggia
Silvia Fattoruso
P2860
P2888
P356
10.1186/1756-9966-32-67
P577
2013-09-17T00:00:00Z
P5875
P6179
1041327328